ClinicalTrials.gov
ClinicalTrials.gov Menu

Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00021151
Recruitment Status : Completed
First Posted : April 13, 2004
Last Update Posted : January 9, 2014
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Case Comprehensive Cancer Center